关注
Subir Goyal
Subir Goyal
Biostatistician Senior, Winship Cancer Institute of Emory University
在 emory.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone
TM Schmidt, BG Barwick, N Joseph, LT Heffner, CC Hofmeister, L Bernal, ...
Blood Cancer Journal 9 (12), 94, 2019
1622019
18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label …
AB Jani, E Schreibmann, S Goyal, R Halkar, B Hershatter, PJ Rossi, ...
The Lancet 397 (10288), 1895-1904, 2021
1332021
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers
M Yarchoan, L Cope, AN Ruggieri, RA Anders, AM Noonan, LW Goff, ...
The Journal of Clinical Investigation 131 (24), 2021
572021
Immune-related adverse events as clinical biomarkers in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors
DJ Martini, S Goyal, Y Liu, ST Evans, TA Olsen, K Case, BL Magod, ...
The Oncologist 26 (10), e1742-e1750, 2021
292021
Immune-related adverse events as clinical biomarkers in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors
DJ Martini, S Goyal, Y Liu, ST Evans, TA Olsen, K Case, BL Magod, ...
The Oncologist 26 (10), e1742-e1750, 2021
292021
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy
DA Bond, JM Switchenko, D Villa, K Maddocks, M Churnetski, AS Gerrie, ...
Blood Advances 5 (23), 5179-5189, 2021
272021
Mismatch Repair (MMR) gene alteration and BRAF V600E mutation are potential predictive biomarkers of immune checkpoint inhibitors in MMR-deficient colorectal cancer
IH Sahin, S Goyal, Y Pumpalova, MB Sonbol, S Das, S Haraldsdottir, ...
The oncologist 26 (8), 668-675, 2021
272021
Body composition variables as radiographic biomarkers of clinical outcomes in metastatic renal cell carcinoma patients receiving immune checkpoint inhibitors
DJ Martini, TA Olsen, S Goyal, Y Liu, ST Evans, B Magod, JT Brown, ...
Frontiers in Oncology 11, 707050, 2021
262021
Body composition as an independent predictive and prognostic biomarker in advanced urothelial carcinoma patients treated with immune checkpoint inhibitors
DJ Martini, JM Shabto, S Goyal, Y Liu, TA Olsen, ST Evans, BL Magod, ...
The Oncologist 26 (12), 1017-1025, 2021
202021
Multi‐center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab era
R Karmali, JM Switchenko, S Goyal, K Shanmugasundaram, ...
American journal of hematology 96 (11), 1374-1384, 2021
192021
MERTK activation drives osimertinib resistance in EGFR-mutant non–small cell lung cancer
D Yan, JM Huelse, D Kireev, Z Tan, L Chen, S Goyal, X Wang, SV Frye, ...
The Journal of clinical investigation 132 (15), 2022
172022
Intellectual functioning among case‐matched cohorts of children treated with proton or photon radiation for standard‐risk medulloblastoma
BR Eaton, GW Fong, LM Ingerski, MB Pulsifer, S Goyal, C Zhang, ...
Cancer 127 (20), 3840-3846, 2021
172021
Efficacy and safety of immune checkpoint blockade in self‐identified black patients with advanced non–small cell lung cancer
B Nazha, S Goyal, Z Chen, A Engelhart, JW Carlisle, TJ Beardslee, H Gill, ...
Cancer, 2020
172020
Salvage radiotherapy management decisions in postprostatectomy patients with recurrent prostate cancer based on 18f-fluciclovine PET/CT guidance
OA Abiodun-Ojo, AB Jani, AA Akintayo, OO Akin-Akintayo, OA Odewole, ...
Journal of Nuclear Medicine 62 (8), 1089-1096, 2021
162021
Construct validation and comparison of a novel postoperative quality-of-life metric and the Short Form-36 in colorectal surgery patients
DS Keller, MF McGee, S Goyal, T Nobel, BOB Ermlich, VK Cheruvu, ...
Surgery 154 (4), 690-696, 2013
162013
Initial Report of a Randomized Trial Comparing Conventional-vs Conventional plus Fluciclovine (18F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer
A Jani, E Schreibmann, S Goyal, H Raghuveer, B Hershatter, PJ Rossi, ...
International Journal of Radiation Oncology, Biology, Physics 108 (5), 1397, 2020
152020
Analysis of Outcomes and Predictors of Response in Patients with Relapsed Mantle Cell Lymphoma Treated with Brexucabtagene Autoleucel
JT Romancik, S Goyal, JN Gerson, HJ Ballard, Y Sawalha, DA Bond, ...
Blood 138, 1756, 2021
142021
Maintenance rituximab improves outcomes in mantle cell lymphoma patients who respond to induction therapy with bendamustine+ rituximab without autologous transplant
BT Hill, JM Switchenko, P Martin, MC Churnetski, Y Sawalha, S Goyal, ...
Blood 134, 1525, 2019
142019
Regional nodal irradiation for clinically node-positive breast cancer patients with pathologic negative nodes after neoadjuvant chemotherapy
A Schlafstein, Y Liu, S Goyal, S Kahn, K Godette, J Lin, MA Torres, ...
Clinical breast cancer 22 (2), 127-135, 2022
112022
Outcomes following early relapse in patients with mantle cell lymphoma
DA Bond, JM Switchenko, KJ Maddocks, MC Churnetski, S Goyal, ...
Blood 134, 753, 2019
112019
系统目前无法执行此操作,请稍后再试。
文章 1–20